ערך בספרים למניה: BeiGene (ONC)

The book value per share for BeiGene Ltd (ONC) helps assess the expansion of Brukinsa and the effectiveness of R&D cost controls. Current capital volatility is driven by high research expenditures amid growing sales. The global rollout of new therapies is creating real momentum for development. The latest value is recorded as 45.51, which clearly illustrates the stepped changes in the company's equity following the publication of quarterly reports.

Book value per share reflects the portion of net equity available to the security holder after all liabilities are settled. The calculation is based on the ratio of equity to the number of shares. By analyzing the key book value metric on GURU.Markets, an investor can see the impact of BeiGene Ltd (ONC) ESG investments in sustainable waste disposal on its assets. This indicator's trend confirms the fundamental stability of the business, while the upward trajectory signals a strengthening of the company's material base.